CLINICAL RESEARCH IN EMERGENCY MEDICINE
Professor Daniel Fatovich, Emergency physician and clinical researcher
Royal Perth Hospital Emergency Department &
Head of the Centre for Clinical Research in Emergency Medicine (CCREM)
Harry Perkins Institute of Medical Research &
Clinical Professor, UWA Medical School, Emergency Medicine
University of Western Australia, Western Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | September 2025
Professor Daniel Fatovich is a senior emergency physician and clinical researcher at Royal Perth Hospital Emergency Department (ED), with over 30 years’ experience in the design and conduct of clinical research in Emergency Medicine. He is also Head of the Centre for Clinical Research in Emergency Medicine (CCREM) within the Harry Perkins Institute of Medical Research.
He is Professor of Emergency Medicine, University of Western Australia; Director of Research for East Metropolitan Health Service (EMHS), providing strategic advice and leadership; Board Member of the Royal Perth Hospital Research Foundation; Chair of the EMHS Research Advisory Committee.
Professor Fatovich was an inaugural executive member of the Australasian College for Emergency Medicine (ACEM) Research Committee (2019-2024) and the Clinical Trials Network (2018-2024) and has received over $33m in competitive grant funding.
In 2020 and 2023, he was Ministerial adviser for the passage of the Guardianship and Administration (Medical Research) Act Western Australia. In 2017-18, he was deputy chair of the WA Methamphetamine Taskforce. He is chief investigator for the Emerging Drugs Network of Australia (EDNA), which he describes as the most fabulous project of his career. This is best exemplified by a famous quote from Victor Hugo: there is nothing so powerful as an idea whose time has come. EDNA is a national toxico-surveillance system for detecting illicit, emerging and novel psychoactive substances, in presentations to sentinel Emergency Departments. In 2024, EDNA won a WA Health Excellence Award for Excellence in Research and Innovation, and the 2024 UWA Vice-Chancellor’s Award in Research Impact and Innovation.
Expertscape ranks him in the top 1% globally for expertise in Emergency Medicine. He loves to challenge doctors to think, and to think differently.
Source: Supplied
-
Non-invasive tools for CVD screening and monitoring
Dr Hadi Afsharan is a Research Fellow Cardiovascular Science & Diabetes at the Harry Perkins Institute of Medical Research; is a translational research and innovation fellow in medical technologies at The University of Western Australia, holding dual titles as Translational Fellow and Innovation Fellow within UWA’s Medical School and the FHRI (Future Health Research and Innovation) program.
-
Trials in treating STIs, vaccines and lipid lowering medications
Since joining Paratus Clinical Research in 2022, Dr Pi Lip Seet has served as both Principal Investigator and Sub-Investigator across Phase I–IV industry-sponsored clinical trials. His research experience spans vaccines, immunology, cardiovascular and endocrine disease, respiratory medicine, gastroenterology, pain management, sleep medicine and adult psychiatry. He has been involved in multiple vaccine development programs, including RSV, influenza, COVID-19, herpes zoster and pneumococcal studies.
-
Renal care & data linkage of Tasmanian kidney disease cases
Professor Matthew Jose is a Renal Physician & Head of the Renal Unit at the Royal Hobart Hospital, and Professor of Medicine for the University of Tasmania.
Winner of the 2021 Rural Science Award from the Australia and New Zealand Society of Nephrology, he has worked in regional, rural and remote Australian locations for nearly 20 years as a Renal Physician, including the Northern Territory.
